Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Aston Sci. logo — Empowering Patients with Innovative Cancer Immunotherapy

Aston Sci.

Empowering Patients with Innovative Cancer Immunotherapy

Founded 2018 Korea South Korea South 8 employees Series C Total: $27.00B Biotechnology, Pharmaceutical

General Information

Company Name Aston Sci.
Founded Year 2018
Location Korea South Korea South +3
Founders / Decision Makers
Team member
Employees 8
Industries Biotechnology, Pharmaceutical
Funding Stage Series C
Social

Get notified when Aston Sci. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Aston Sci.

Aston Sci. is a clinical-stage biopharmaceutical company founded in 2018, headquartered in Korea South. The company's slogan, "Empowering Patients with Innovative Cancer Immunotherapy," aligns with its focus on developing innovative medicines in oncology, immunology, and geriatrics. This includes therapeutic cancer vaccines and proteostasis modulators. Aston Sci.'s last investment was a significant KRW27.00B Series C round on 12 January 2021, with participation from prominent investors such as Mirae Asset, Mirae Asset Venture Investment, Timefolio Asset Management, Lakewood Partners, and Gen-tech Investments. The company's mission to prioritize human well-being positions it as a compelling player in the Biotechnology and Pharmaceutical industries. With its innovative approach to cancer immunotherapy, Aston Sci. presents a promising opportunity for venture capital consideration.

Taxonomy: clinical-stage biopharmaceutical, oncology, immunology, cancer immunotherapy, therapeutic cancer vaccines, proteostasis modulators, geriatrics, DNA, mRNA, peptide, drug development, pharmaceuticals, innovation

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series C •••••• 5
Investor Investor Investor
•••• •••• 		12 Jan 2021

Aston Sci. Alternatives & Competitors

Aston Sci. vs
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute United States

Dana-Farber Cancer Institute is committed to providing expert, compassionate care to children and ad...

Grant
9027 employees
Health Care
Aston Sci. vs
Michiana Hematology Oncology (MHO)
Michiana Hematology Oncology (MHO) United States

Bringing world-class cancer care to northern Indiana

53 employees
Health Care, Health and Wellness
Aston Sci. vs
Rutgers Cancer Institute
Rutgers Cancer Institute United States

Rutgers Cancer Institute is committed to providing the most advanced, comprehensive, and compassiona...

Grant
909 employees
Health Care

FAQ About Aston Sci.

Empowering Patients with Innovative Cancer Immunotherapy
Aston Sci. was founded in 2018.
Aston Sci. is headquartered in Korea South.
Aston Sci. operates in the following industries: Biotechnology, Pharmaceutical.
Aston Sci. has approximately 8 employees.
Aston Sci. has completed 1 funding round, raising a total of $27.00B. The latest funding stage is Series C.
Top alternatives and competitors to Aston Sci. include Dana-Farber Cancer Institute, Michiana Hematology Oncology (MHO), Rutgers Cancer Institute, University of Colorado Anschutz Cancer Center, Remicalm. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Aston Sci. and Dana-Farber Cancer Institute are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Aston Sci. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy